Is This Company the Big Winner in Obama’s Push for Precision Medicine? | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 14 February, 2015 by The TZ Newswire Staff

Is This Company the Big Winner in Obama’s Push for Precision Medicine?

Illumina gene sequencing demand could head higher thanks to President Obama’s precision medicine plan.

See also
- Next Article Why the Electric Car Won’t Kill Oil
- Previous Article This Top Tech Investor Believes Bitcoins Will Beat Apple Pay
Editorial Calender

February 2015

M T W T F S S

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28

« Jan Mar »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar